Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma
Stoeck, Alexander, Lejnine, Serguei, Truong, Andrew, Pan, Li, Wang, Hongfang, Zang, Chongzhi, Yuan, Jing, Ware, Chris, MacLean, John, Garrett-Engele, Philip W, Kluk, Michael, Laskey, Jason, Haines, Brian B, Moskaluk, Christopher, Zawel, Leigh, Fawell, Stephen, Gilliland, Gary, Zhang, Theresa, Kremer, Brandon E, Knoechel, Birgit, Bernstein, Bradley E, Pear, Warren S, Liu, X Shirley, Aster, Jon C, Sathyanarayanan, Sriram
Published in Cancer discovery (01.10.2014)
Published in Cancer discovery (01.10.2014)
Get full text
Journal Article
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study
Cousin, Sophie, Blay, Jean‐Yves, Garcia, Irene Braña, Bono, Johann S., Le Tourneau, Christophe, Moreno, Victor, Trigo, Jose, Hann, Christine L., Azad, Arun A., Im, Seock‐Ah, Cassier, Philippe A., French, Christopher A., Italiano, Antoine, Keedy, Vicki L., Plummer, Ruth, Sablin, Marie‐Paule, Hemming, Matthew L., Ferron‐Brady, Geraldine, Wyce, Anastasia, Khaled, Ahmed, Datta, Antara, Foley, Shawn W., McCabe, Michael T., Wu, Yuehui, Horner, Thierry, Kremer, Brandon E., Dhar, Arindam, O'Dwyer, Peter J., Shapiro, Geoffrey I., Piha‐Paul, Sarina A.
Published in International journal of cancer (15.03.2022)
Published in International journal of cancer (15.03.2022)
Get full text
Journal Article
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11
Iida, Shinsuke, Sunami, Kazutaka, Mishima, Yuko, Fujii, Taku, Kato, Hitomi, Terao, Takumi, Matsuzawa, Yuki, Matsubara, Mari, Crossman, Timothy, Kremer, Brandon E., Gupta, Ira
Published in International journal of hematology (01.11.2023)
Published in International journal of hematology (01.11.2023)
Get full text
Journal Article
An Adaptive Physiologically Based Pharmacokinetic–Driven Design to Investigate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Molibresib (GSK525762) in Healthy Female Volunteers
Riddell, Kylie, Patel, Aarti, Collins, Gary, Zhou, Yanyan, Schramek, Dan, Kremer, Brandon E., Ferron‐Brady, Geraldine
Published in Journal of clinical pharmacology (01.01.2021)
Published in Journal of clinical pharmacology (01.01.2021)
Get full text
Journal Article
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Dawson, Mark A, Borthakur, Gautam, Huntly, Brian J P, Karadimitris, Anastasios, Alegre, Adrian, Chaidos, Aristeidis, Vogl, Dan T, Pollyea, Daniel A, Davies, Faith E, Morgan, Gareth J, Glass, Jacob L, Kamdar, Manali, Mateos, Maria-Victoria, Tovar, Natalia, Yeh, Paul, Delgado, Regina García, Basheer, Faisal, Marando, Ludovica, Gallipoli, Paolo, Wyce, Anastasia, Krishnatry, Anu Shilpa, Barbash, Olena, Bakirtzi, Evi, Ferron-Brady, Geraldine, Karpinich, Natalie O, McCabe, Michael T, Foley, Shawn W, Horner, Thierry, Dhar, Arindam, Kremer, Brandon E, Dickinson, Michael
Published in Clinical cancer research (16.02.2023)
Published in Clinical cancer research (16.02.2023)
Get full text
Journal Article
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design
Nooka, Ajay K, Weisel, Katja, van de Donk, Niels Wcj, Routledge, David, Otero, Paula Rodriguez, Song, Kevin, Quach, Hang, Callander, Natalie, Minnema, Monique C, Trudel, Suzanne, Jackson, Nicola A, Ahlers, Christoph M, Im, Ellie, Cheng, Shinta, Smith, L, Hareth, Nahi, Ferron-Brady, Geraldine, Brouch, Maria, Montes de Oca, Rocio, Paul, Sofia, Holkova, Beata, Gupta, Ira, Kremer, Brandon E, Richardson, Paul
Published in Future oncology (London, England) (01.06.2021)
Published in Future oncology (London, England) (01.06.2021)
Get full text
Journal Article
Myocardin Is a Key Regulator of CArG-Dependent Transcription of Multiple Smooth Muscle Marker Genes
Yoshida, Tadashi, Sinha, Sanjay, Dandré, Frédéric, Wamhoff, Brian R, Hoofnagle, Mark H, Kremer, Brandon E, Wang, Da-Zhi, Olson, Eric N, Owens, Gary K
Published in Circulation research (02.05.2003)
Published in Circulation research (02.05.2003)
Get full text
Journal Article
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms
Watts, Justin, Minden, Mark D, Bachiashvili, Kimo, Brunner, Andrew M, Abedin, Sameem, Crossman, Timothy, Zajac, Magdalena, Moroz, Veronica, Egger, Jacqueline L, Tarkar, Aarti, Kremer, Brandon E, Barbash, Olena, Borthakur, Gautam
Published in Therapeutic advances in hematology (01.01.2024)
Published in Therapeutic advances in hematology (01.01.2024)
Get full text
Journal Article
P983: DREAMM‐20: A STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF BELANTAMAB FOR THE TREATMENT OF MULTIPLE MYELOMA WHEN USED AS MONOTHERAPY AND IN COMBINATION TREATMENTS
Quach, Hang, Fulci, Giulia, Ratia, Nirav, Clements, John, Lewis, Eric, Ahras, Malika, Kaptanis, Sarantos, Kremer, Brandon E.
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
Anderson, Kenneth C, Auclair, Daniel, Adam, Stacey J, Agarwal, Amit, Anderson, Melissa, Avet-Loiseau, Hervé, Bustoros, Mark, Chapman, Jessica, Connors, Dana E, Dash, Ajeeta, Di Bacco, Alessandra, Du, Ling, Facon, Thierry, Flores-Montero, Juan, Gay, Francesca, Ghobrial, Irene M, Gormley, Nicole J, Gupta, Ira, Higley, Howard, Hillengass, Jens, Kanapuru, Bindu, Kazandjian, Dickran, Kelloff, Gary J, Kirsch, Ilan R, Kremer, Brandon, Landgren, Ola, Lightbody, Elizabeth, Lomas, Oliver C, Lonial, Sagar, Mateos, María-Victoria, Montes de Oca, Rocio, Mukundan, Lata, Munshi, Nikhil C, O'Donnell, Elizabeth K, Orfao, Alberto, Paiva, Bruno, Patel, Reshma, Pugh, Trevor J, Ramasamy, Karthik, Ray, Jill, Roshal, Mikhail, Ross, Jeremy A, Sigman, Caroline C, Thoren, Katie L, Trudel, Suzanne, Ulaner, Gary, Valente, Nancy, Weiss, Brendan M, Zamagni, Elena, Kumar, Shaji K
Published in Clinical cancer research (01.10.2021)
Published in Clinical cancer research (01.10.2021)
Get full text
Journal Article
DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Usmani, Saad Z., Alonso Alonso, Aránzazu, Quach, Hang, Koh, Youngil, Guenther, Andreas, Min, Chang-Ki, Zhou, Xiaoou L., Kaisermann, Morrys, Mis, Lukasz M., Williams, Danaè, Yeakey, Anne, Ferron-Brady, Geraldine, Figueroa, David J., Kremer, Brandon E., Gupta, Ira, Janowski, Wojciech
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
DREAMM-8: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) Vs Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Trudel, Suzanne, Davis, Randy, Lewis, Nicole M., Bakshi, Kalpana K., Chopra, Bikramjit, Montes de Oca, Rocio, Ferron-Brady, Geraldine, Eliason, Laurie, Kremer, Brandon E., Gupta, Ira, Wu, Frank S.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
P-305 DREAMM-20: a study to investigate the safety and efficacy of belantamab for the treatment of multiple myeloma (MM) when used as monotherapy and in combination treatments
Quach, Hang, Huang, Shang-Yi, Lin, Hsuan-Yu, Yoon, Dok Hyun, Fulci, Giulia, Ratia, Nirav, Clements, John, Lewis, Eric, Sun, Wei, Ahras, Malika, Kaptanis, Sarantos, Shafi-Harji, Seema, Kremer, Brandon, Min, Chang-Ki
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Syndrome and Acute Myeloid Leukemia
Watts, Justin M., Bradley, Terrence J, Thomassen, Amber, Brunner, Andrew M., Minden, Mark D., Papadantonakis, Nikolaos, Abedin, Sameem, Baines, Amanda J, Barbash, Olena, Gorman, Shelby, Kremer, Brandon E, Borthakur, Gautam M.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
DREAMM-7: A Phase III Study of the Efficacy and Safety of Belantamab Mafodotin (Belamaf) with Bortezomib, and Dexamethasone (B-Vd) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Rifkin, Robert M., Boyd, Kevin, Grosicki, Sebastian, Kim, Kihyun, Di Raimondo, Francesco, Dimopoulos, Meletios A, Weisel, Katja, Arnulf, Bertrand, Hajek, Roman, Hungria, Vania T.M., Spencer, Andrew, Davis, Randy, Riccio, Antonio, Kim, Chanbin, Wilkes, Jodie, Rutledge, Ruth, Talekar, Mala, Kremer, Brandon E., Gupta, Ira, Mateos, Maria-Victoria
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
DREAMM-6: Safety, Tolerability and Clinical Activity of Belantamab Mafodotin (Belamaf) in Combination with Bortezomib/Dexamethasone (BorDex) in Relapsed/Refractory Multiple Myeloma (RRMM)
Popat, Rakesh, Nooka, Ajay, Stockerl-Goldstein, Keith, Abonour, Rafat, Ramaekers, Ryan, Khot, Amit, Forbes, Adam, Lee, Cindy, Augustson, Bradley, Spencer, Andrew, Mateos, Maria-Victoria, Chopra, Bikramjit, Rogers, Rachel, Smith, Deborah A, Davidge, Jacqueline, Montes de Oca, Rocio, Ferron-Brady, Geraldine, Yeakey, Anne, Talekar, Mala, Kremer, Brandon E., Gupta, Ira, Quach, Hang
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
MM-533 Low-Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat Versus Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM-5 Platform Sub-Study 3
Callander, Natalie S., Richardson, Paul G., Hus, Marek, Ribrag, Vincent, Lopez, Joaquin Martinez, Kim, Kihyun, Lee, Jae Hoon, Dimopoulos, Meletis, Schjesvold, Fredrik, Facon, Thierry, Jo, Jae-Cheol, Min, Chang-Ki, Mielnik, Michał, Cheng, Shinta, Smith, L. Mary, Breitbach, Caroline J., Brawley, Chris, Sembhi, Harjeet, LaMacchia, John, Hakim, Shawn, Kremer, Brandon E., Grosicki, Sebastian
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article